Home / Trials and Studies/ Trial or Study

CANCOV 2.0

Principal Investigator(s):

Margaret Herridge, Angela Cheung

Status: Enrolling

CANCOV 2.0 will refine and disseminate the framework for rapid knowledge to action (K2A) cycles derived from the 1-year CANCOV dataset with an extension to 2-year follow-up and with a specific focus on vulnerable populations. This program will inform how longer-term disability relates to symptoms in the post COVID‑19 condition. Further, it will highlight potentially modifiable outcomes for vulnerable Canadians who contracted COVID‑19 by informing risk profiles for longer-term clinical and resource use trajectories to better advance planning by health service providers and policy makers.

For more information see CANCOV